ÂÜÀòÂÒÂ×

Kimberly Brown PhD, founder and CEO of Amethyst Technologies, began working in the biotechnology compliance industry in 1998 as an intern for Cell Systems, Inc. while pursuing her doctorate degree. At the time, the company had one employee, the owner, and provided services to Walter Reed¡¯s Pilot Bioproduction Facility (WRAIR PBF). After completing her studies, Dr. Brown continued to work for Cell Systems as validation manager for WRAIR PBF and as Cell Systems¡¯ operations manager.

She increased the project scope at WRAIR PBF to include quality system development, custom software to support FDA-regulated activities, and the validation master plan to ensure sterile vaccines, increasing the contract with the addition of validation services, managing the environmental monitoring system, and commissioning for clean rooms and utilities.

Dr. Brown purchased the contract rights from Cell Systems, Inc. in February 2007, and received the contract to continue providing services to WRAIR PBF. Since then, Amethyst Technologies has experienced steady growth in employees, client base, and revenues. Under her guidance, Amethyst Technologies has grown from two employees to more than 40. Amethyst is a prime contractor to the US Army, USAID, NIH, FDA, Department of State, and the CDC. Amethyst operates in the US, Africa, and Middle East.